[Federal Register Volume 64, Number 82 (Thursday, April 29, 1999)]
[Notices]
[Page 23087]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-10695]
[[Page 23087]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Radiological Devices Panel of the Medical Devices Advisory
Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Radiological Devices Panel of the Medical
Devices Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on May 17, 1999, 9 a.m. to
5:30 p.m.
Location: Corporate Bldg., conference rm. 020B, 9200 Corporate
Blvd., Rockville, MD.
Contact Person: Robert J. Doyle, Center for Devices and
Radiological Health (HFZ-470), Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850, 301-594-1212, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 12526. Please call the Information Line for
up-to-date information on this meeting.
Agenda: The committee will discuss bone strength assessment, with a
focus on the use of gender-specific and race-specific data bases in
assessing fracture risk and their applicability to bone densitometry
and sonometry device labeling.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by May 6, 1999.
Oral presentations from the public will be scheduled between
approximately 9:45 a.m. and 10:15 a.m., and for an additional 30
minutes near the end of the committee deliberations. Time allotted for
each presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before May 6, 1999, and
submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Closed Committee Deliberations: On May 17, 1999, from 12:15 p.m. to
12:45 p.m., the meeting will be closed to the public to permit
discussion and review of trade secret and/or confidential commercial
information (5 U.S.C. 552b(c)(4)) relating to present and future agency
issues.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: April 23, 1999.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 99-10695 Filed 4-28-99; 8:45 am]
BILLING CODE 4160-01-F
